srch

21.01.2022 · The EBioMedicine Impact Factor IF measures the average number of citations received in a particular year (2021) by papers published in the EBioMedicine during the two preceding years (2019-2020). Note that 2021 Impact Factor are reported in 2022; they cannot be calculated until all of the 2021 publications have been processed by the indexing agency.

The journal publishes original research that elucidates, or aims to modify, disease pathways and mechanisms?with the goal of advancing our knowledge in any ...

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. Journal Citation Reports (Clarivate Analytics, 2020) Five Year Impact Factor: 8.333. Five Year Impact Factor.

Our Impact Factor is 8·143: Learn more about our reach and impact. In conversation with: Our Editors and the journal's authors explore their research and ...

eBioMedicine is the premium gold open access venue for translational biomedical research. The journal publishes original research that elucidates, ...

Our new Impact Factor is 8·143 (2020 Journal Citation Reports®, Clarivate 2021). Learn more about our reach and impact, and submit your best ...

eBioMedicine is the premium gold open access venue for translational biomedical research. The journal publishes original research that elucidates, or aims to modify, disease pathways and mechanisms?with the goal of advancing our knowledge in any biomedical discipline with relevance to human health as well as relevant reviews, commentaries, and opinion pieces.

Over several years, Dr Lundberg successfully raised the journal's impact factor to around 11, while those of the Annals of Internal Medicine and the BMJ rose ...

EBioMedicine open access. Country. Netherlands ... The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

eBioMedicine is the premium gold open access venue for translational biomedical research. The journal publishes original research that elucidates, or aims to modify, disease pathways and mechanisms?with the goal of advancing our knowledge in any biomedical discipline with relevance to human health as well as relevant reviews, commentaries, and opinion pieces.

Impact factor of EBioMedicine. Impact Factor. 3.44. 2020-21.

18.08.2020 · EBioMedicine has an Impact Factor of 8·143 and ranks 17th among 140 research and experimental medicine journals globally (2020 Journal Citation Reports®, Clarivate 2021). We recognise that the Journal Impact Factor is just one measure of a journal's performance and encourage authors to explore additional journal impact metrics , which provide a means to …

EBioMedicine ; Elsevier · Continuous · Yes · 8.143 (2020).

Dec 24, 2021 · Our Impact Factor is 8·143: Learn more about our reach and impact. In conversation with: Our Editors and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Nov 16, 2021 · The impact score (IS) 2020 of EBioMedicine is 5.57, which is computed in 2021 as per its definition. EBioMedicine IS is increased by a factor of 1.36 and approximate percentage change is 32.3% when compared to preceding year 2019, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal.

24.12.2021 · EBioMedicine is a leading biomedical open access journal, ... Our Impact Factor is 8·143: Learn more about our reach and impact. In conversation with: Our Editors and the journal’s authors explore their research and its impact on people’s health, health care, ...

eBioMedicine covers the whole spectrum of biomedical research, from preclinical studies with clear human relevance, through to proof-of-concept studies and clinical trials. The journal aspires to catalyse dialogue and collaboration between basic scientists, clinical researchers and healthcare professionals, enhance the accessibility and applicability of basic research findings for health professionals, and promote a better understanding of clinical challenges for biomedical researchers.